Expert Opinion on Emerging Drugs

Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease
pp. 341-343(3)
Authors: Cozzolino, Mario; Brancaccio, Diego

Emerging therapeutic agents for onychomycosis
pp. 345-353(9)
Authors: E Piérard, Gérald; E Arrese, Jorge; Quatresooz, Pascale; PiÉrard-Franchimont, C

Emerging drugs for hyperphosphatemia
pp. 355-365(11)
Authors: Bellinghieri, Guido; Santoro, Domenico; Savica, Vincenzo

Pharmacologic therapeutics for cardiac reperfusion injury
pp. 367-388(22)
Authors: Gross, Eric R; Gross, Garrett J

Advances in hemorrhagic stroke therapy: conventional and novel approaches
pp. 389-406(18)
Authors: Lapchak, Paul A; Araujo, Dalia M

Emerging drugs for epilepsy
pp. 407-422(16)
Authors: Kwan, Patrick; Brodie, Martin J

Emerging drugs for attention-deficit/hyperactivity disorder
pp. 423-434(12)
Author: Weisler, Richard H

Emerging drugs for targeted therapy of bladder cancer
pp. 435-448(14)
Authors: Agarwal, Piyush K; Black, Peter C; McConkey, David J; Dinney, Colin PN

Emerging drugs for non-small-cell lung cancer
pp. 449-460(12)
Authors: Felip, Enriqueta; Santarpia, Mariacarmela; Rosell, Rafael

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome
pp. 461-477(17)
Authors: Bosma, Karen J; Lewis, James F

Emerging adenosine receptor agonists
pp. 479-492(14)
Authors: Gao, Zhan-Guo; Jacobson, Kenneth A

Emerging pharmacologic therapies for osteoporosis
pp. 493-508(16)
Author: Grey, Andrew